Objective:

To develop a population pharmacokinetic (PopPK) model for vancomycin in adult burn patients and evaluate its predictive performance.

Approach:

Key Findings:

• A one-compartment model best described vancomycin pharmacokinetics in burn patients.
• Creatinine clearance (CrCL) was identified as a significant covariate affecting clearance.
• The final model showed superior predictive accuracy compared to Clincalc.

Interpretation:

Limitations:

• The study was limited to a single center and may not be generalizable to all burn patients.
• The sample size, while larger than previous studies, may still limit the robustness of the findings.

Conclusion:

The developed PopPK model provides a basis for individualized vancomycin dosing in adult burn patients.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.